A KINETIC-MODEL OF BENZOYLECGONINE DISPOSITION AFTER COCAINE ADMINISTRATION IN HUMANS

被引:20
作者
AMBRE, JJ [1 ]
CONNELLY, TJ [1 ]
RUO, TI [1 ]
机构
[1] NORTHWESTERN UNIV,SCH MED,DEPT MED,CLIN PHARMACOL SECT,CHICAGO,IL 60611
关键词
D O I
10.1093/jat/15.1.17
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Cocaine (C) and benzoylecgonine (BZ) plasma levels and urinary excretion rate data from a series of intravenous cocaine studies were used to develop a kinetic model for C and BZ, with the main objective of characterizing BZ disposition. Kinetic analyses were made with the CONSAM 30 computer program. Under assumptions of the model, calculated parameters indicated a BZ distribution volume of 50 L, a half-time for BZ formation of 1.9 h and a BZ excretion half-time of 4.7 h. The model may eventually provide a basis for interpretation of analytical data on isolated samples of plasma or urine.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 15 条
  • [1] URINARY-EXCRETION OF ECGONINE METHYL-ESTER, A MAJOR METABOLITE OF COCAINE IN HUMANS
    AMBRE, J
    FISCHMAN, M
    RUO, TI
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1984, 8 (01) : 23 - 25
  • [2] URINARY-EXCRETION OF COCAINE, BENZOYLECGONINE, AND ECGONINE METHYL-ESTER IN HUMANS
    AMBRE, J
    RUO, TI
    NELSON, J
    BELKNAP, S
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1988, 12 (06) : 301 - 306
  • [3] THE URINARY-EXCRETION OF COCAINE AND METABOLITES IN HUMANS - A KINETIC-ANALYSIS OF PUBLISHED DATA
    AMBRE, J
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1985, 9 (06) : 241 - 245
  • [4] ACUTE TOLERANCE TO COCAINE IN HUMANS
    AMBRE, JJ
    BELKNAP, SM
    NELSON, J
    RUO, TI
    SHIN, SG
    ATKINSON, AJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) : 1 - 8
  • [5] AMBRE JJ, UNPUB KINETICS COCAI
  • [6] BENET LZ, 1985, GOODMAN GILMANS PHAR, P26
  • [7] BERMAN M, 1978, US DHEW NIH78180 PUB
  • [8] KINETICS OF COCAINE DISTRIBUTION, ELIMINATION, AND CHRONOTROPIC EFFECTS
    CHOW, MJ
    AMBRE, JJ
    RUO, TI
    ATKINSON, AJ
    BOWSHER, DJ
    FISCHMAN, MW
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (03) : 318 - 324
  • [9] GIBALDI M, 1982, PHARMACOKINETICS, P1
  • [10] INABA T, 1978, CLIN PHARMACOL THER, V23, P547